• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refocusing Medication Prior Authorization on Its Intended Purpose.

作者信息

Resneck Jack S

机构信息

Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.

Department of Dermatology, School of Medicine, University of California, San Francisco.

出版信息

JAMA. 2020 Feb 25;323(8):703-704. doi: 10.1001/jama.2019.21428.

DOI:10.1001/jama.2019.21428
PMID:32011641
Abstract
摘要

相似文献

1
Refocusing Medication Prior Authorization on Its Intended Purpose.将药物预先授权重新聚焦于其预期目的。
JAMA. 2020 Feb 25;323(8):703-704. doi: 10.1001/jama.2019.21428.
2
Changing the Game of Prior Authorization: The Patient Perspective.改变预先授权的游戏规则：患者视角
JAMA. 2020 Feb 25;323(8):705-706. doi: 10.1001/jama.2020.0070.
3
First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.第一年的医疗保险处方药福利：双重资格精神疾病患者的药物获取和连续性。
J Clin Psychiatry. 2010 Apr;71(4):400-10. doi: 10.4088/JCP.08m04608whi. Epub 2009 Nov 17.
4
Utilization Management Trends in Medicare Part D Oncology Drugs, 2010-2020.2010 - 2020年医疗保险D部分肿瘤药物的使用管理趋势
JAMA. 2023 Jul 18;330(3):278-280. doi: 10.1001/jama.2023.10753.
5
Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries.医保受益人群中，处方集排除和限制类阿片替代药物与阿片类药物处方之间的关联。
JAMA Netw Open. 2020 Mar 2;3(3):e200274. doi: 10.1001/jamanetworkopen.2020.0274.
6
Top 40 Medicare Part D prescription drugs Ranked by total payments in 2014.2014年按总支付金额排名的医疗保险D部分前40种处方药。
Mod Healthc. 2016 Oct;46(36):42.
7
Cost-related nonadherence in the Medicare program: the impact of Part D.医疗保险计划中的与费用相关的不依从性：Part D 的影响。
Med Care. 2011 May;49(5):522-6. doi: 10.1097/MLR.0b013e318210443d.
8
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.医疗保险受益人的处方药费用分担的影响。
Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.
9
Pharmaceutical demand response to utilization management.药品需求对利用管理的响应。
J Health Econ. 2024 Jan;93:102830. doi: 10.1016/j.jhealeco.2023.102830. Epub 2023 Nov 7.
10
Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.医疗保险受益人中处方药保险与医疗保健利用之间的关联
Med Care Res Rev. 2018 Apr;75(2):153-174. doi: 10.1177/1077558716681920. Epub 2016 Dec 1.

引用本文的文献

1
Open Access to Antipsychotics in State Medicaid Programs: Effect on Healthcare Resource Utilization and Costs among Patients with Serious Mental Illness.州医疗补助计划中抗精神病药物的开放获取：对严重精神疾病患者医疗资源利用和成本的影响。
J Health Econ Outcomes Res. 2025 Jun 17;12(1):222-229. doi: 10.36469/001c.137909. eCollection 2025.
2
Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV prevention.将平价医疗法案合格健康计划进行聚类，以了解保险如何以及在何处促进或阻碍艾滋病毒预防。
AIDS Res Ther. 2024 Nov 19;21(1):83. doi: 10.1186/s12981-024-00674-9.
3
A primer on copay accumulators, copay maximizers, and alternative funding programs.
关于共付额累积器、共付额最大化器及替代筹资计划的入门知识。
J Manag Care Spec Pharm. 2024 Aug;30(8):883-896. doi: 10.18553/jmcp.2024.30.8.883.
4
The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation.从一线视角看丙型肝炎消除工作现状：一项定性研究调查了医疗服务提供者在启动治疗方面存在的认知差距。
J Gen Intern Med. 2024 Sep;39(12):2268-2276. doi: 10.1007/s11606-024-08807-6. Epub 2024 May 23.
5
Comparison of prior authorization across insurers: cross sectional evidence from Medicare Advantage.比较不同保险公司的预先授权：来自 Medicare Advantage 的横断面证据。
BMJ. 2024 Mar 7;384:e077797. doi: 10.1136/bmj-2023-077797.
6
Discordance Between Inflammatory Bowel Disease Specialists and Insurance Authorization Denials-A Survey of Specific Inflammatory Bowel Disease Treatment Scenarios.炎症性肠病专家与保险授权拒绝之间的不一致——特定炎症性肠病治疗方案的调查
Crohns Colitis 360. 2023 Dec 30;6(1):otad082. doi: 10.1093/crocol/otad082. eCollection 2024 Jan.
7
Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis.HIV 暴露前预防的合格健康计划覆盖范围和事先授权要求的地域差异。
JAMA Netw Open. 2023 Nov 1;6(11):e2342781. doi: 10.1001/jamanetworkopen.2023.42781.
8
The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?预授权系统：炎症性肠病生物治疗剂量递增的预先授权是一种可容忍的选择还是一种持续的困扰？
Dig Dis Sci. 2023 Dec;68(12):4279-4281. doi: 10.1007/s10620-023-08100-2. Epub 2023 Oct 4.
9
The association between cost sharing, prior authorization, and specialty drug utilization: A systematic review.费用分担、事先授权与专科药物使用之间的关联：系统评价。
J Manag Care Spec Pharm. 2023 May;29(5):449-463. doi: 10.18553/jmcp.2023.29.5.449.
10
Is Time Spent on Prior Authorizations Associated With Approval?花在预先授权上的时间与批准有关吗？
J Nurse Pract. 2023 Feb;19(2). doi: 10.1016/j.nurpra.2022.10.008. Epub 2022 Nov 10.